2 new clinical trials conducted in France and the Netherlands has uncovered new innovative ways of administering chemotherapy to pancreatic cancer patients in an effort to extend survival rates.
By creating a chemotherapy cocktail comprised of 4 drugs, researchers in France "extended surgical patients' lives by nearly two years over the current single-drug chemo regimen", while the study in the Netherlands determined that "combining chemotherapy and radiation therapy before pancreatic cancer surgery" extended survival rate, especially for patients who successfully had tumours removed.
To read more about these clinical trials, click here.
No comments:
Post a Comment